Skip to main content
. 2021 Sep 25;10(10):1240. doi: 10.3390/pathogens10101240

Table 2.

Antibiotic susceptibility of S. Enteritidis strains (n = 345) isolated from different ecological niches in regions of Siberia and the Far East of Russia.

S. Enteritidis Strains Isolated from Different Ecological Niches (n = 345) Susceptibility Number of Strains (%)
AMP CEF CXM CTX FEP STR KAN GEN AMK TET NAL CIP IMI CHL SXT
Sporadic cases
(n = 255)
R 1 2.7 0.4 0.4 1.6 0.7 0.4 5.9 53.7 0.4 5.0 1.2
I 2 0.4 5.9 0.4 0.4 11.4 51.8 14.1 9.0 1.6 2.0 8.2 0.4
S 3 97.3 99.2 94.1 99.2 99.6 87,1 47.4 85.5 91.0 92.5 44.3 91.4 100 95.0 98.4
Outbreak cases
(n = 41)
R 2.4 14.6 61.0 12.2
I 7.3 4.9 34.1 2.4 2.4
S 100 100 92.7 100 100 92.7 65.9 97.6 100 85.4 36.7 100 100 87.8 100
Food
(n = 46)
R 2.2 4.3 52.2 4.3
I 8.7 2.2 32.6 8.7 2.2 2.2 4.3 10.9
S 97.8 100 91.3 100 100 97.8 67.4 91.3 97.8 91.3 43.5 98.1 100 95.6 100
Environment
(n = 3)
R 66.7 66.7 66.7 33.3
I 33.3
S 100 100 100 100 100 100 66.7 100 100 33.3 33.3 100 100 33.3 66.7

1 R—resistant, 2 I—Intermediate, 3 S—Susceptible. Antibiotics used: Ampicillin 10 μg (AMP), cephalexin 30 μg (CEF), cefuroxime 30 μg (CXM), cefotaxime 30 μg (CTX), cefepime 30 μg (FEP), streptomycin 10 μg (STR), kanamycin 30 μg (KAN), gentamicin 30 μg (GEN), amikacin 30 μg (AMK), tetracycline 30 μg (TET), nalidixic acid 30 μg (NAL), ciprofloxacin 5 μg (CIP), imipenem 10 μg (IMI), chloramphenicol 30 μg (CHL), and trimethoprim 1.25 μg/sulfamethoxazole 23.75 μg (SXT).